Perception of adults toward electronic cigarettes: a cross-sectional study from Jordan.


Journal

Primary health care research & development
ISSN: 1477-1128
Titre abrégé: Prim Health Care Res Dev
Pays: England
ID NLM: 100897390

Informations de publication

Date de publication:
28 01 2021
Historique:
entrez: 28 1 2021
pubmed: 29 1 2021
medline: 21 9 2021
Statut: epublish

Résumé

The rate of Jordanian tobacco smokers has been reported to be one of the highest rates in the world. The electronic cigarette (E-cig) has become an option, or an alternative, to tobacco cigarette smoking. This study was aimed to measure the perception of Jordanian adults toward E-cig use. A cross-sectional study design was used. A self-administered survey was developed and validated to solicit anonymous responses from the study participants. A convenience sample (n = 984) was recruited electronically through social media platforms. Descriptive statistics and correlation analyses were completed using the Statistical Package for the Social Sciences (SPSS). More than half of the participants (53%) were females, and almost all participants had heard about E-cig (99.2%), mainly from their friends (40%) and social media (34.5%). About half of the participants were nonsmokers and around one-third of them (33.1%) were current E-cig users. The majority of the participating E-cig users had replaced tobacco with E-cig (56.4%)/All the E-cig users reported positive beliefs toward the E-cig as a safer alternative for tobacco smoking. About 45% of participants believed that the E-cig is helpful in tobacco smoking cessation, but should be highly regulated. This study illustrated a significant prevalence of E-cig usage among Jordanian adults. E-cig users perceived E-cig as a safer and cheaper alternative to tobacco smoking and that it helps in tobacco smoking cessation. However, health awareness campaigns are needed for the entire Jordanian community about E-cig use, related emerging health findings, and how to promote tobacco smoking cessation.

Identifiants

pubmed: 33504409
pii: S1463423621000062
doi: 10.1017/S1463423621000062
pmc: PMC8057464
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e3

Références

Prim Health Care Res Dev. 2018 Mar;19(2):189-196
pubmed: 28774353
Environ Sci Technol. 2016 Sep 6;50(17):9644-51
pubmed: 27461870
Am J Health Behav. 2015 May;39(3):361-71
pubmed: 25741681
Bull World Health Organ. 2017 Jul 1;95(7):540-541
pubmed: 28670020
Tob Control. 2014 Jul;23 Suppl 3:iii17-25
pubmed: 24935893
Prev Med Rep. 2017 Aug 05;8:25-29
pubmed: 28831370
N Engl J Med. 2019 Feb 14;380(7):629-637
pubmed: 30699054
Internet Interv. 2016 Apr 27;4:72-81
pubmed: 30135792
Sci Transl Med. 2011 Nov 2;3(107):107ra109
pubmed: 22049069
Addict Behav. 2014 Jun;39(6):1120-5
pubmed: 24679611
Oncotarget. 2016 Nov 22;7(47):77196-77204
pubmed: 27791204
Int J Chron Obstruct Pulmon Dis. 2019 Aug 30;14:1943-1950
pubmed: 32021137
Respir Res. 2016 May 17;17(1):58
pubmed: 27183972
Addiction. 2013 Jun;108(6):1115-25
pubmed: 23551515
Am J Physiol Lung Cell Mol Physiol. 2019 Aug 1;317(2):L155-L166
pubmed: 31042077
OTO Open. 2018 May 09;2(2):2473974X18774543
pubmed: 30480216
Tob Induc Dis. 2018 Oct 10;16:48
pubmed: 31516445
Prev Med Rep. 2018 Apr 18;10:332-336
pubmed: 29868388
Respir Res. 2016 May 17;17(1):53
pubmed: 27184265
Gac Sanit. 2015 Jul-Aug;29(4):296-9
pubmed: 25757692
BMC Med Educ. 2018 Mar 2;18(1):32
pubmed: 29499682
East Mediterr Health J. 2014 Oct 12;20(9):529-37
pubmed: 25343465
Tob Induc Dis. 2019 Mar 04;17:17
pubmed: 31582928
Eur Respir Rev. 2018 Feb 28;27(147):
pubmed: 29491036
Risk Anal. 1986 Dec;6(4):417-24
pubmed: 3602513
J Family Med Prim Care. 2019 Sep 30;8(9):2921-2926
pubmed: 31681668
BMJ. 2004 May 29;328(7451):1312-5
pubmed: 15166072
JAMA Intern Med. 2014 May;174(5):812-3
pubmed: 24664434

Auteurs

Muna Barakat (M)

Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.

Areej M Assaf (AM)

Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, The University of Jordan, Amman, Jordan.

Raja'a Al-Qudah (R)

Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.

Samar Thiab (S)

Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.

Manar Alhamed (M)

Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.

Hala J Al-Obaidi (HJ)

Clinical and Practice Research Group, School of Pharmacy, Queen's University Belfast, Belfast, UK.

Feras J Jirjees (FJ)

Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.

Iman Basheti (I)

Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH